AFFORDABLE CARE ACT
Reform reimagined
What should life sciences companies know about risk adjustment for the Medicare, Medicaid, and ACA markets?
With the 2027 Affordable Care Act out-of-pocket maximum limits released, we recommend some action steps for group health plan sponsors.
The expiration of enhanced ACA subsidies resets market dynamics, reshaping enrollment patterns and risk pools across the individual market.
This analysis quantifies the value of enhanced subsidies, examines the differences in their value by cohort and geography, and considers the potential disruption to the individual market.
